mortality/aging
• mice challenged with RMAS or B16 tumors exhibit increased lethality compared with similarly treated wild-type mice
|
immune system
• NK and CD8+ T cell death in the tumor ascites from mice transplanted with RMAS cells is decreased compared to that of similarly treated wild-type mice and further decreased after T reg depletion
|
• NK and CD8+ T cell death in the tumor ascites from mice transplanted with RMAS cells is decreased compared to that of similarly treated wild-type mice and further decreased after T reg depletion
|
neoplasm
• tumor burden in mice challenged with RMAS cells is increased compared to in similarly treated wild-type mice
|
cellular
• NK and CD8+ T cell death in the tumor ascites from mice transplanted with RMAS cells is decreased compared to that of similarly treated wild-type mice and further decreased after T reg depletion
|
hematopoietic system
• NK and CD8+ T cell death in the tumor ascites from mice transplanted with RMAS cells is decreased compared to that of similarly treated wild-type mice and further decreased after T reg depletion
|
• NK and CD8+ T cell death in the tumor ascites from mice transplanted with RMAS cells is decreased compared to that of similarly treated wild-type mice and further decreased after T reg depletion
|